Zhongtai Securities(SH:600918) Xin Lang Cai Jing·2025-09-05 06:21Group 1 - The core viewpoint of the news is that Shenzhen Xinlitai Pharmaceutical Co., Ltd. has seen a stock price increase of 5.11%, reaching 57.21 CNY per share, with a total market capitalization of 63.779 billion CNY [1] - The company was established on November 3, 1998, and went public on September 10, 2009. Its main business involves the research, production, and sales of pharmaceuticals and medical devices [1] - The revenue composition of the company is as follows: formulations account for 81.69%, medical devices 8.54%, raw materials 7.17%, and others 2.59% [1] Group 2 - From the perspective of fund holdings, one fund under Zhongtai Securities Asset Management has a significant position in Xinlitai, specifically the Zhongtai Xingrui Economic Growth Mixed A Fund (018372), which reduced its holdings by 24,800 shares in the second quarter [2] - As of the latest data, the fund holds 70,300 shares of Xinlitai, representing 3.07% of the fund's net value, making it the fourth-largest holding [2] - The fund has achieved a year-to-date return of 31.77% and a one-year return of 41.31%, ranking 1412 out of 8178 and 2904 out of 7978 in its category, respectively [2]